Delivery Order SPE2DB25D3020-SPE2DB25FWKRL
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,370.16 on August 8, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors under a firm fixed-price contract. The award was competitively procured with no set-aside designation and is scheduled for completion by August 11, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,625.80 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injections. This is a firm fixed price, non-set-aside contract with performance scheduled for completion by August 12, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 25, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. The contract carries a ceiling value of $14,492.64 and is structured as a firm fixed price delivery order with an ultimate completion date of September 26, 2025. This award was competitively awarded with no set-aside designation and represents a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,016.72 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded transaction under the company's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,237.27 by the Defense Logistics Agency on August 13, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and was awarded competitively with no set-aside designation. The award demonstrates the agency's continued reliance on AmerisourceBergen as a critical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,519.60 on September 17, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections (0.5 ml units) under a firm fixed-price contract with no set-aside designation. The order is set to be completed by September 18, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with the Defense...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,478.28 by the Defense Logistics Agency on August 14, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 15, 2025. This award falls under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections, valued at $6,035.72. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,287.74 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $11,161.15 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on August 5, 2025, with completion scheduled for August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively through an open procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...